Repeat Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemoperfusion is Feasible and Offers Survival Benefit in Select Patients with Peritoneal Metastases

INTRODUCTION. We hypothesized that repeat cytoreductive surgery-hyperthermic intraperitoneal chemoperfusion (CRS-HIPEC) for peritoneal metastases (PM) may be associated with suboptimal resection, more frequent postoperative complications, and worse oncologic outcomes. METHODS. Using a prospectively...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ann Surg Oncol
Hauptverfasser: Choudry, Haroon A., Bednar, Filip, Shuai, Yongli, Jones, Heather L., Pai, Reetesh K., Pingpank, James F., Ahrendt, Steven S., Holtzman, Matthew P., Zeh, Herbert J., Bartlett, David L.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2019
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7170006/
https://ncbi.nlm.nih.gov/pubmed/30825033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-019-07218-w
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge